CHRS

Coherus Oncology, Inc.

NasdaqGM · Healthcare

$1.59

+1.60% today

last filing 2026-06-05Pro sees filings in ~15 min

Price

hover · 4 moves explained

1 sell

Analyst consensus

Strong Buy

$7.80target+392.1%vs $1.59 today

$4.00 low today target$12.00 high

5 analysts · ~12-month consensus · as of Jul 7. Relayed analyst opinion, which tends to run optimistic — not our forecast or advice.

Earnings

Beat 1 of last 4

Earnings per share · actual vs forecast

Q2 '25-25.2%

−$0.34

exp −$0.27

Q3 '25-13.8%

−$0.33

exp −$0.29

Q4 '25-1.5%

−$0.34

exp −$0.34

Q1 '26+5.7%

−$0.25

exp −$0.27

Type	Date	Insider	Title	Of stake	Shares	Price	Value
Grant	2026-06-09	Satvat Ali J.	Director	—Direct	30,000	—	—
Grant	2026-06-09	Karachun Rita A	Director	—Direct	30,000	—	—
Grant	2026-06-09	Newcomer Lee Nisley	Director	—Direct	30,000	—	—
Grant	2026-06-09	Ryan Michael Lee	Director	—Direct	30,000	—	—
Grant	2026-06-09	O'Donnell-Tormey Jill	Director	—Direct	30,000	—	—

Grant

Satvat Ali J.

Director · 2026-06-09

—

30,000 shares

Grant

Karachun Rita A

Director · 2026-06-09

—

30,000 shares

Grant

Newcomer Lee Nisley

Director · 2026-06-09

—

30,000 shares

Grant

Ryan Michael Lee

Director · 2026-06-09

—

30,000 shares

Grant

O'Donnell-Tormey Jill

Director · 2026-06-09

—

30,000 shares

7 more transactions on ProFull insider transaction history is a Pro feature.

Upgrade →